Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13

6 février 2018

08:00
CellMax Life, a leading cancer diagnostics company enabling early cancer detection and management with globally affordable non-invasive blood tests, today announced results from a new 200-patient study showing that its circulating tumor cell (CTC)...

08:00
- Phase 1 study to examine safety and tolerability of U3-1402, a potential first-in-class HER3-targeting antibody drug conjugate (ADC), in patients with metastatic EGFR-mutated NSCLC - Patients with EGFR-mutated NSCLC who experience disease...

07:50
Oska Wellness, a technology company committed to developing consumer health and wellness products, has released the results of a randomized double-blind placebo study showing significant results in pain reduction by using Oska Pulse.  The clinical...

07:30
Endo International plc today announced the initiation of two identical Phase 3 RELEASE* clinical trials of collagenase clostridium histolyticum (CCH) for the treatment of cellulite. The multicenter, randomized, double-blind, placebo-controlled...

07:30
Endo International plc today announced the initiation of two identical Phase 3 RELEASE* clinical trials of collagenase clostridium histolyticum (CCH) for the treatment of cellulite. The multicenter, randomized, double-blind, placebo-controlled...

07:06
Compugen Ltd. , a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced the online publication of the discovery and validation of the ILDR2 protein as a novel immune checkpoint and its...

06:45
Allergan plc, , a leading global pharmaceutical company today announced positive results from ACHIEVE I (UBR-MD-01), the first of two pivotal phase 3 clinical trials evaluating the efficacy, safety and tolerability of orally administered ubrogepant...


5 février 2018

18:00
United States Drug Testing Laboratories, Inc. (USDTL), a pioneer in newborn forensic toxicology, alcohol biomarkers, and substances of abuse testing has announced a breakthrough in measuring Phosphatidylethanol (PEth) in newborn blood. PEth is an...

17:10
Astellas Pharma Inc. (TSE: 4503), President and CEO: Yoshihiko Hatanaka, "Astellas," and Pfizer Inc. announced today results from the Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC). The results...

12:00
A new study, led by scientists at Human Longevity, Inc., along with an international team of academic and commercial researchers, has shown the potentially negative impact of the widely used, over?the-counter drug acetaminophen (paracetamol) on sex...

11:00
In a study of nearly 6,000 community-based patients with chronic kidney disease and heart failure, the use of implantable cardioverter defibrillators was associated with a significantly increased risk of subsequent hospitalization....

09:00
Valerion Therapeutics, a clinical-stage biotechnology company that specializes in the development of therapies for orphan genetic diseases, today announced that a poster highlighting initial results from the first cohort of its ongoing Phase 1/2...

09:00
Medial EarlySign (www.earlysign.com), a leader of machine-learning based solutions to improve non-communicable disease management, today announced the results of an additional clinical data study in the domain of diabetes - identifying diabetic...

09:00
CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today highlighted that aldoxorubicin licensee NantCell, Inc., a private subsidiary of NantWorks, LLC, has dosed the first patient in the Phase 1b...

08:40
A recent paper has been published detailing the implementation process of the Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study, the first and only randomized clinical trial on UVC disinfection. The new report, Implementation Lessons...

08:30
Cryoport, Inc. ("Company"), the world's leading temperature controlled logistics company dedicated to the life sciences industry, today announced that Cryoport will support TiGenix (Euronext Brussels and NASDAQ: TIG) as it conducts its SEPCELL phase...

08:18
Trethera Corporation, a biopharmaceutical company committed to developing novel drugs targeting cellular nucleotide metabolism for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared its...

08:08
Eisai Inc. today announced the publication of results from a subgroup analysis of the pivotal Phase 3 study comparing eribulin mesylate (marketed as Halaven® Injection) with dacarbazine in previously treated patients with advanced liposarcoma (LPS)...

08:00
GigaGen Inc., a biopharmaceutical company developing a pipeline of novel antibody therapies, has published a study in collaboration with authors from a leading antibody drug developer that sheds new light on methods for increasing the success of...

08:00
Johnson & Johnson Vision announced today the simultaneous publication of two studies in Clinical Ophthalmology demonstrating the patient and clinical benefits of LipiFlow® treatment for meibomian gland dysfunction (MGD), the leading cause of dry eye...

08:00
Genomic Health, Inc. today announced the publication of real-world clinical evidence demonstrating that use of the Oncotype DX® Genomic Prostate Scoretm (GPStm) test resulted in significantly higher use of active surveillance at six and 12 months...

07:55
CTI BioPharma Corp. (CTI BioPharma) today announced the launch of a proposed underwritten public offering of shares of its common stock. In addition, CTI BioPharma expects to grant the underwriters a 30-day option to purchase additional shares of...

07:30
Palatin Technologies, Inc. , a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced that the first healthy...

07:00
Tessa Therapeutics (Tessa), a clinical stage immunotherapy company, announced that the Stanford Cancer Institute...


2 février 2018

19:00
A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists at NYU Langone Health....

16:44
Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company developing a new class of Clean Surface Nanotherapeutic (CSNTM) drugs using an electro-crystal-chemistry drug development platform, announced today results from multiple preclinical...


1 février 2018

15:00
"You absolutely cannot give whole food to someone on a feeding tube," said the hospital's registered dieticians. "It will kill him." Robin Gentry McGee was watching her father's health fade before her eyes, feeling...

14:34
AZTherapies, Inc., établie à Boston, au Massachusetts, une société pharmaceutique privée spécialisée dans le développement de médicaments en phase clinique avancée, met au point des traitements novateurs pour la maladie d'Alzheimer (MA), l'accident...

14:17
An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for hemodialysis access was presented today at Leipzig Interventional Course (LINC) 2018. The meta-analysis, which analyzed...

13:45
AZTherapies, Inc. est une société pharmaceutique privée de stade clinique avancé située à Boston, dans le Massachusetts, qui développe des traitements révolutionnaires de la maladie d'Alzheimer (AD), de l'accident ischémique cérébral et d'autres...

12:26
On January 19, 2018, the global first clinical case of MitralStitchtm mitral valve repair system was completed at Yunnan Fuwai Hospital, China. This operation was jointly performed by the team of Professor Pan Xiangbin and Professor Meng Xu from...

10:17
Harvest One Cannabis Inc. ("Harvest One" or the "Company") through its wholly-owned subsidiary Satipharm AG ("Satipharm") is pleased to announce its proprietary capsules were used in a Phase 2 Clinical Trials undertaken by Israeli-based PhytoTech...

10:00
The Welch Foundation today announced that Dr. Jeffrey D. Rimer is the recipient of the 2018 Norman Hackerman Award in Chemical Research. Having already made significant scientific contributions in the areas of energy and drug development, Dr. Rimer...

09:11
Harvest One Cannabis Inc. ("Harvest One" or the "Company") through its wholly-owned subsidiary Satipharm AG ("Satipharm") is pleased to announce its proprietary capsules were used in a Phase 2 Clinical Trials undertaken by Israeli-based PhytoTech...

08:30
SCYNEXIS, Inc. , a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced new preclinical data supporting the potential of SCY-078, the Company's lead product...

08:30
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced that six posters evaluating investigational Cladribine Tablets in multiple sclerosis (MS) will be presented at the Americas Committee...

07:45
Panacea Pharmaceuticals, a clinical stage biopharmaceutical company developing novel biologically-targeted cancer therapies and diagnostics for unmet medical needs, announced today the completion of patient enrollment in an open-label,...

07:00
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") , a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced a new clinical collaboration with AstraZeneca  to evaluate the safety...

07:00
Imago BioSciences, a clinical-stage pharmaceutical company developing novel therapies for hematological and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted their Investigational New Drug (IND)...

07:00
The Food and Drug Administration has issued official guidance, giving the green light to reimburse patients for travel expenses to clinical trial sites. It allows all cancer patients access to potentially life-saving treatments....

03:30
Results from the SUSTAIN 7 trial, which investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 mg dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin, have been published in The Lancet...


31 janvier 2018

23:00
ClinOne, a mobile clinical trial management solution, is revolutionizing how patients manage the complexities of a clinical trial, navigate appointments, and manage their research documents with the first proactive patient engagement monitoring...

17:09
Novartis today announced updated results from the pivotal ELIANA clinical trial of Kymriahtm (tisagenlecleucel), formerly CTL019, in relapsed or refractory (r/r) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL) have...

17:00
Updated results from a global clinical trial of the CAR T-cell therapy, tisagenlecleucel, a landmark personalized treatment for a high-risk form of acute lymphoblastic leukemia (ALL), reveal that children and young adults continued to show high rates...

14:55
A study in AACC's The Journal of Applied Laboratory Medicine has for the first time established female-specific reference ranges for several biological variables that play key roles in thrombosis?or blood clotting?during pregnancy. This research...

14:26
AZTherapies, Inc. is a privately held advanced clinical stage pharmaceutical company located in Boston, MA that is developing breakthrough treatments for Alzheimer's disease (AD), ischemic stroke, and other neurological diseases associated with...

12:00
A new study* by researchers at the Massachusetts Institute of Technology found that nearly 14% of all drugs in clinical trials eventually win approval from the FDA?an amount that is much higher than previous studies indicate. The researchers also...

09:04
SkylineDx today announced a strategic collaboration with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making for melanoma patients. For SkylineDx, the collaboration with the renowned Mayo Clinic is an important...

08:15
OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, announced today that Nikhilesh N. Singh, Ph.D., President and Chief Executive Officer, will present at the 20th Annual BIO CEO & Investor...

08:00
Medidata , the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership to transform oncology clinical trials for the age...

1 2 3 4 5 6 7 8 9 10 11 12 13